Engene Therapeutics Inc (ENGN) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ENGN Annual Balance Sheets →
This page allows investors to track Engene Therapeutics Inc's balance sheet development across multiple reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Apr 30 2026)
(Jan 31 2026) (Oct 31 2025) (Jul 31 2025) (Apr 30 2025)
Assets
Cash & cash equivalent29.83
Marketable Securities, Current SH228.64
Cash & Short-term Investments257.00
Other Current Assets0.90
Prepaid Expense And Other Assets Current10.64
Total Current Assets270.00
Equipment/Property/Plant Net2.34
Long-term investments26.71
Other Assets, Noncurrent35.19
Investment Tax Credits Receivable0.82
Total Assets307.52
Liabilities
Accounts Payable, Current AC1.79
Accrued Liabilities And Other Liabilities17.21
Notes Payable, Current NO0.19
Other Liabilities, Current0.00
Taxes Payable0.00
Total Current Liabilities21.49
Long-term debt24.91
Total Long-term Debt24.91
Other liabilities, Noncurrent5.96
Operating Lease Liability Current2.29
Total Liabilities52.36
Stockholders' Equity
Common Stock Value632.00
Additional Paid In Capital Common Stock56.33
Retained Earnings / Accumulated Deficit-432.01
Accumulated Other Comprehensive Income0.00
Other Equity-1.14
Common Stockholder's Equity255.17
Total Stockholder's Equity255.17
Liabilities & Stockholder's Equity307.52
4 historic quarters locked

Sign in to unlock the full Engene Therapeutics Inc balance sheet history.

About Engene Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-270386

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.